Zinplava (bezlotoxumab) for the Treatment of Clostridium Difficile Infection

Zinplava (bezlotoxumab) is an injectable solution developed by Merck indicated for the treatment of clostridium difficile infection (CDI) in adult patients who are already receiving anti-bacterial drug treatment.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news